LS Investment Advisors, LLC - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
LS Investment Advisors, LLC ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$154,000
+37.5%
13,720
+34.5%
0.01%
+28.6%
Q2 2017$112,000
+10.9%
10,203
-1.1%
0.01%
+16.7%
Q1 2017$101,000
+381.0%
10,320
+425.2%
0.01%
+500.0%
Q4 2016$21,000
+5.0%
1,9650.0%0.00%0.0%
Q3 2016$20,000
-23.1%
1,9650.0%0.00%
-50.0%
Q2 2016$26,0001,9650.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Athos Capital Ltd 410,389$4,596,0003.46%
GLG Partners LP 2,586,437$28,968,0001.54%
Nine Chapters Capital Management LLC 32,300$362,0000.80%
FNY Partners Fund LP 335,900$3,762,0000.64%
MENTA CAPITAL LLC 373,523$4,183,0000.61%
Yakira Capital Management, Inc. 85,500$958,0000.32%
Sapphire Star Partners LP 18,724$209,0000.27%
GAM Holding AG 541,025$6,059,0000.26%
Bowling Portfolio Management LLC 127,873$1,432,0000.22%
Kassirer Asset Management Corp 15,000$168,0000.16%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders